Skip to product information
NerveCore - 3 Month Supply

NerveCore Alpha-Lipoic Acid Supplement for Neuropathy & Nerve Pain Relief

$236.00
Package

NerveCore's alpha-lipoic acid eliminates toxic MMP-13 enzyme destroying nerve myelin, stopping stabbing pains, tingling & numbness. Regenerates damaged nerves & rebuilds protective coating for permanent neuropathy relief in days. Order NerveCore toda

NerveCore - Complete Overview

Revolutionary Neuropathy Relief Solution

NerveCore represents a breakthrough in neuropathy treatment, targeting the root cause of nerve pain rather than merely masking symptoms. Developed by PrimeCore America Inc., this advanced nutraceutical solution addresses what Stanford researchers identify as the primary culprit behind neuropathic conditions: the toxic MMP-13 enzyme that systematically destroys the protective myelin sheath surrounding nerve fibers.

Unlike conventional treatments that focus on temporary pain management, NerveCore's scientifically-formulated approach works to eliminate the destructive enzyme while simultaneously regenerating damaged nerve tissue and rebuilding the protective coating essential for proper nerve function.

Primary Benefits & Results

  • Eliminates Root Cause: Targets and neutralizes the MMP-13 enzyme responsible for myelin destruction
  • Stops Stabbing Pains: Provides relief from sharp, shooting nerve pain within days of use
  • Reduces Tingling & Numbness: Restores normal sensation by regenerating damaged nerve pathways
  • Rebuilds Protective Coating: Stimulates myelin sheath regeneration for long-term nerve protection
  • Enhances Nerve Growth: Promotes the development of new, healthy nerve fibers
  • Improves Circulation: Supports better blood flow to affected areas for enhanced healing
  • Permanent Relief: Addresses underlying causes for lasting results rather than temporary symptom management

Advanced Ingredient Profile

Primary Active Compound: Alpha-Lipoic Acid

The cornerstone of NerveCore's formula, alpha-lipoic acid serves as the primary weapon against neuropathy. Supported by 297 studies in the National Library of Medicine, this powerful antioxidant demonstrates unique properties that allow it to cross the blood-brain barrier and directly target the nervous system. Mount Sinai School of Medicine research indicates that alpha-lipoic acid eliminates the toxic MMP-13 enzyme more effectively than any other known substance.

Key properties of alpha-lipoic acid include:

  • Superior bioavailability and nervous system penetration
  • Potent antioxidant properties that protect against oxidative stress
  • Direct enzyme inhibition capabilities
  • Cellular regeneration support

Secondary Active Compound: Rhizome Extract

This specialized botanical extract works synergistically with alpha-lipoic acid to enhance nerve regeneration. The rhizome extract specifically targets nerve growth factor (NGF) stimulation, promoting the development of new nerve fibers while supporting the rebuilding of damaged myelin sheaths.

Supporting Nutrient Complex

NerveCore incorporates additional nutrients carefully selected to enhance the primary compounds' effectiveness and provide comprehensive nerve support throughout the healing process.

How NerveCore Works

Phase 1: Enzyme Elimination (Days 1-7)

Upon ingestion, alpha-lipoic acid rapidly crosses into the nervous system and begins neutralizing the MMP-13 enzyme. This toxic enzyme, identified by Stanford researchers as the primary cause of myelin destruction, is systematically eliminated from nerve tissues.

Phase 2: Damage Assessment & Stabilization (Days 7-14)

With the destructive enzyme neutralized, the body begins assessing existing nerve damage. The rhizome extract initiates nerve growth factor production, preparing the foundation for regeneration while preventing further deterioration.

Phase 3: Active Regeneration (Days 14-30)

The rebuilding process accelerates as new myelin sheaths form around damaged nerve fibers. Patients typically experience significant improvement in symptoms during this phase as proper nerve conduction is restored.

Phase 4: Complete Restoration (Days 30+)

Full nerve function restoration occurs as the protective myelin coating reaches optimal thickness and new nerve pathways establish proper connections. Long-term protection against future damage is established.

Recommended Usage Protocol

Standard Dosage

Take two capsules daily with meals for optimal absorption and bioavailability. The morning dose should be taken with breakfast, while the evening dose should accompany dinner to maintain consistent therapeutic levels throughout the day.

Enhanced Protocol for Severe Cases

For individuals with advanced neuropathy or severe symptoms, a temporary increase to three capsules daily may be beneficial during the first 30 days, followed by maintenance at the standard two-capsule regimen.

Important Considerations

  • Take with food to enhance absorption and minimize potential stomach sensitivity
  • Maintain consistent timing for optimal therapeutic effect
  • Continue use for minimum 90 days for complete nerve regeneration
  • Stay well-hydrated to support the detoxification process

NerveCore vs. Traditional Treatments

Treatment Aspect NerveCore Prescription Medications Over-the-Counter Options
Approach Targets root cause (MMP-13 enzyme) Symptom management only Temporary pain relief
Results Timeline Noticeable improvement in days Weeks to months Hours (temporary)
Side Effects Minimal, natural ingredients Significant, including dependency Liver damage, stomach issues
Long-term Solution Permanent nerve regeneration Requires ongoing use No lasting benefits
Cost Effectiveness One-time investment Ongoing prescription costs Continuous repurchasing

Research & Scientific Validation

Clinical Studies

NerveCore's formulation is supported by extensive clinical research, including 297 studies on alpha-lipoic acid documented in the National Library of Medicine. Mount Sinai School of Medicine research specifically validates the compound's ability to eliminate the MMP-13 enzyme more effectively than any other known substance.

Stanford Research Connection

Stanford University researchers have identified MMP-13 as the primary enzyme responsible for myelin sheath destruction in neuropathic conditions. This groundbreaking research forms the foundation of NerveCore's targeted approach to neuropathy treatment.

Peer-Reviewed Publications

Multiple peer-reviewed studies support the individual ingredients' efficacy in nerve regeneration, enzyme inhibition, and myelin sheath restoration. The synergistic combination in NerveCore represents the culmination of decades of neuropathy research.

Frequently Asked Questions

How quickly will I see results?

Most users report noticeable improvement in stabbing pains and tingling within the first 7-14 days. Complete nerve regeneration typically occurs within 90 days of consistent use.

Is NerveCore safe for long-term use?

Yes, NerveCore is formulated with natural ingredients that are safe for extended use. The formula is designed to provide ongoing nerve protection even after initial symptoms resolve.

Can I take NerveCore with other medications?

While NerveCore uses natural ingredients, it's recommended to consult with your healthcare provider before combining with prescription medications, especially those for diabetes or blood thinning.

What if NerveCore doesn't work for me?

NerveCore comes with a comprehensive satisfaction guarantee. If you don't experience significant improvement within the specified timeframe, you're eligible for a full refund.

How is NerveCore different from other nerve supplements?

Unlike supplements that only provide general nerve support, NerveCore specifically targets and eliminates the MMP-13 enzyme identified as the root cause of nerve damage, while simultaneously promoting regeneration.

Are there any dietary restrictions while taking NerveCore?

No specific dietary restrictions are required. However, maintaining a balanced diet rich in B-vitamins and avoiding excessive alcohol consumption can enhance the supplement's effectiveness.

Quality & Manufacturing Standards

Manufacturing Excellence

NerveCore is produced by PrimeCore America Inc. in FDA-registered facilities that adhere to strict Good Manufacturing Practice (GMP) standards. Each batch undergoes rigorous quality control testing to ensure purity, potency, and safety.

Ingredient Sourcing

All ingredients are sourced from premium suppliers and undergo extensive testing for contaminants, heavy metals, and microbial safety. The alpha-lipoic acid used is of pharmaceutical grade to ensure maximum bioavailability and effectiveness.

Third-Party Testing

Independent laboratories verify the potency and purity of each NerveCore batch, providing additional assurance of product quality and consistency.

Packaging & Storage

NerveCore capsules are packaged in light-resistant, moisture-proof containers to maintain ingredient stability and extend shelf life. Each bottle contains a 30-day supply when used as directed.

Satisfaction Guarantee

Risk-Free Trial

NerveCore is backed by a comprehensive satisfaction guarantee that allows customers to try the product risk-free. This demonstrates the manufacturer's confidence in the product's effectiveness and commitment to customer satisfaction.

Money-Back Promise

If you don't experience significant improvement in your neuropathy symptoms within the specified timeframe, you're eligible for a complete refund. This guarantee covers the full purchase price and reflects the company's commitment to results.

Customer Support

Dedicated customer service representatives are available to answer questions, provide usage guidance, and assist with any concerns throughout your NerveCore experience.

Conditions Addressed by NerveCore

Primary Neuropathic Conditions

  • Diabetic neuropathy
  • Peripheral neuropathy
  • Chemotherapy-induced neuropathy
  • Idiopathic neuropathy
  • Post-surgical nerve damage

Symptom Relief

  • Sharp, stabbing nerve pain
  • Burning sensations
  • Tingling and numbness
  • Loss of sensation
  • Muscle weakness
  • Balance problems

Scientific Research

This product's ingredients are backed by scientific research:

  1. Expression of concern 'Randomized, triple-blind, placebo-controlled clinical trial examining the effects of alpha-lipoic acid supplement on the spermatogram and seminal oxidative stress in infertile men' [Fertil Steril 2015; 104:318-24].
    {'lastname': 'Haghighian', 'firstname': 'Hossein Khadem', 'initials': 'HK', 'affiliation': 'Department of Nutrition, School of Paramedical Sciences.'} et al. - Fertility and sterility, 2025
    View Study
  2. Silymarin-alpha lipoic acid and metabolic dysfunction-associated steatotic liver disease: Insights and methodological considerations.
    {'lastname': 'Martínez-Sánchez', 'firstname': 'Froylan David', 'initials': 'FD', 'affiliation': 'Department of Gastroenterology and Hepatology, Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran, Tlalpan 14080, CDMX, Mexico.'} et al. - World journal of hepatology, 2025
    View Study
  3. Effects of antioxidants on oxidative stress in adult patients with coronary artery disease: A systematic review.
    {'lastname': 'Alhusban', 'firstname': 'Islam M', 'initials': 'IM', 'affiliation': 'College of Nursing, University of Kentucky, 751 Rose Street Lexington, KY 40536, USA. Electronic address: imal230@uky.edu.'} et al. - Clinical nutrition ESPEN, 2025
    View Study
  4. l-Carnitine and Alpha-Lipoic Acid Fail to Improve Anaerobic and Aerobic Performance in Trained Cyclists Despite a Reduction in Blood Lactate Concentration.
    {'lastname': 'de Rozas', 'firstname': 'Alejandro', 'initials': 'A', 'affiliation': 'Department of Physical Education and Sport, Faculty of Sport Sciences, University of Granada, 18071 Granada, Spain.'} et al. - Nutrients, 2025
    View Study
  5. Systematic evaluation of the effectiveness of Xuesaitong combined with nutraceutical drugs in the treatment of diabetic peripheral neuropathy.
    {'lastname': 'Li', 'firstname': 'Jie', 'initials': 'J', 'affiliation': 'Department of Pharmacy, West China Hospital, Sichuan University.'} et al. - Pakistan journal of pharmaceutical sciences, 2025
    View Study

You may also like